Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (4): 485-494.doi: 10.19982/j.issn.1000-6621.20250399
• Original Articles • Previous Articles Next Articles
Li Jing1, Zhang Yangyi1, Yang Jinghui2, Wu Zheyuan1, Li Ningdi1, Yu Chenlei1, Wang Lili1, Shen Xuhui1, Jiang Yuan1(
), Shen Xin1(
)
Received:2025-10-09
Online:2026-04-10
Published:2026-04-02
Contact:
Jiang Yuan,Email:jiangyuan@scdc.sh.cn;Shen Xin,Email:shenxin@scdc.sh.cn
Supported by:CLC Number:
Li Jing, Zhang Yangyi, Yang Jinghui, Wu Zheyuan, Li Ningdi, Yu Chenlei, Wang Lili, Shen Xuhui, Jiang Yuan, Shen Xin. Study on the characteristics of rpoB gene mutations in Mycobacterium tuberculosis and its correlation with rifampicin resistance level in Shanghai[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 485-494. doi: 10.19982/j.issn.1000-6621.20250399
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250399
| 利福平耐药基因 突变位点 | 利福平 MIC值(μg/ml) | 利福平(复核) MIC值(μg/ml) | 利福平表型药敏 最终判断结果 |
|---|---|---|---|
| rpoB_p.Ser450Leu | 0.5 | 1/1a | 耐药 |
| rpoB_p.Leu452Pro | 0.5 | 4/4a | 耐药 |
| rpoB_p.Asp435Tyr | 0.5 | 1/1a | 耐药 |
| rpoB_p.Leu430Pro | 0.5 | 0.5 | 敏感 |
| rpoB_p.Leu430Pro | 0.5 | 0.5 | 敏感 |
| rpoB_p.His445Asn | 0.25 | 0.25 | 敏感 |
| rpoB_p.His445Asp | 0.5 | 0.5 | 敏感 |
| rpoB_p.Ser450Cys | 0.5 | 0.5 | 敏感 |
| mtrB_p.Met517Leu | 0.25 | 0.5 | 敏感 |
| mtrB_p.Met517Leu | 0.25 | 0.25 | 敏感 |
| mtrB_p.Met517Leu | 0.5 | 0.5 | 敏感 |
| mtrB_p.Met517Leu | 1 | 1 | 耐药 |
| mtrB_p.Met517Leu | 1 | 1 | 耐药 |
| mtrB_p.Met517Leu,rpoA_p.Cys-123Gly | >16 | >16 | 耐药 |
| mtrB_p.Met517Leu,rpoB_p.Ser431Cys, rpoB p._1290_1291_insGly,rpoA_p.Cys-123Gly | >16 | >16 | 耐药 |
| rpoB RRDR 突变位点 | rpoB non-RRDR突变 位点/其他突变位点 | rpoA | rpoC | 耐药相关性 置信度分级a | 菌株株数 (构成比,%) | 表型耐药 株数 | |
|---|---|---|---|---|---|---|---|
| 单密码子突变 | |||||||
| rpoB450 | |||||||
| rpoB_p.Ser450Leu | - | - | - | 1 | 70(50.36) | 70 | |
| rpoB_p.Ser450Trp | - | - | - | 1 | 3(2.16) | 3 | |
| rpoB_p.Ser450Cys | - | - | - | 2 | 1(0.72) | 0 | |
| rpoB445 | |||||||
| rpoB_p.His445Asp | - | - | - | 1 | 17(12.23) | 16 | |
| rpoB_p.His445Tyr | - | - | - | 1 | 4(2.88) | 4 | |
| rpoB_p.His445Leub | - | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.His445Arg | - | - | - | 1 | 2(1.44) | 2 | |
| rpoB_p.His445Asnb | - | - | - | 1 | 1(0.72) | 0 | |
| rpoB435 | |||||||
| rpoB_p.Asp435Gly | - | - | - | 2 | 2(1.44) | 2 | |
| rpoB_p.Asp435Val | - | - | - | 1 | 2(1.44) | 2 | |
| rpoB_p.Asp435Tyrb | - | - | - | 1 | 4(2.88) | 4 | |
| rpoB452 | |||||||
| rpoB_p.Leu452Prob | - | - | 1 | 6(4.32) | 6 | ||
| rpoB430 | |||||||
| rpoB_p.Leu430Prob | - | - | - | 1 | 4(2.88) | 2 | |
| - | mtrB_p.Met517Leu | - | - | 5 | 5(3.60) | 2 | |
| 多重密码子突变 | |||||||
| rpoB_p.Ser450Leu | - | - | rpoC_p.Gly332Arg | 1 | 1(0.72) | 1 | |
| rpoB_p.Ser450Leu | - | - | rpoC_p.Phe452Ser | 1 | 1(0.72) | 1 | |
| rpoB_p.Ser450Leu | - | - | rpoC_p.Ile491Thr | 1 | 1(0.72) | 1 | |
| rpoB_p.Ser450Leu | rpoB_p.Pro45Leu | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.Ser450Leu | rpoB_p.Pro45Ser | - | - | 1 | 2(1.44) | 2 | |
| rpoB_p.Ser450Leu | rpoB_p.Ala286Val | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.Ser450Leu | rpoB_p.Ile480Val | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.His445Asn | rpoB_p.Asn163Lys | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.His445Pro, rpoB_p.Ser428Arg | - | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.His445Asp, rpoB_p.Asp435Tyr | - | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.Asp435Gly, rpoB_p.Leu430Pro | - | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.Asp435Val, rpoB_p.Leu452Pro | - | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.Ser450Leu, rpoB_p.His445Tyr | rpoB_p.Glu460Gly | - | - | 1 | 1(0.72) | 1 | |
| rpoB_p.Leu452Pro, rpoB_p.His445Asn, rpoB_p.Ser450Leu | - | - | - | 1 | 1(0.72) | 1 | |
| rpoB_ p.Ser431Cysc | mtrB_p.Met517Leu,rpoB p._1290_1291_insGlyc | rpoA_p.Cys-123Gly | - | 5,未知d | 1(0.72) | 1 | |
| - | mtrB_p.Met517Leu | rpoA_p.Cys-123Gly | - | 5,未知d | 1(0.72) | 1 | |
| 合计 | 139(100.00) | 131 | |||||
| 突变类型 | 菌株株数 | MIC[μg/ml,M(Q1,Q3)] | Z值 | P值 | |
|---|---|---|---|---|---|
| rpoB_p.Ser450Leu | 80 | >16(>16,>16) | -13.071 | <0.001a | |
| rpoB_p.Ser450Trp | 3 | >16(>16,>16) | -2.325 | 0.020a | |
| rpoB_p.His445Asp | 18 | >16(>16,>16) | -5.526 | <0.001a | |
| rpoB_p.His445Tyr | 5 | >16(>16,>16) | -3.008 | 0.002a | |
| rpoB_p.His445Arg | 2 | >16(>16,>16) | -1.896 | 0.058 | |
| rpoB_p.His445Asn | 3 | >16(0.25,>16) | -1.221 | 0.222 | |
| rpoB_p.Asp435Gly | 3 | 4(4,>16) | -2.044 | 0.041a | |
| rpoB_p.Asp435Val | 3 | >16(>16,>16) | -2.325 | 0.020a | |
| rpoB_p.Asp435Tyr | 5 | 1(1,10) | -2.040 | 0.041a | |
| rpoB_p.Leu452Pro | 8 | 4(1.25,14) | -2.730 | 0.006a | |
| rpoB_p.Leu430Pro | 5 | 1(0.5,10) | -1.544 | 0.123 | |
| mtrB_p.Met517Leu | 7 | 1(0.5,>16) | -1.574 | 0.115 | |
| rpoB_p.Ser450Cys | 1 | 0.5 | -0.230 | 0.818 | |
| rpoB_p.His445Pro | 1 | >16 | -1.339 | 0.180 | |
| rpoB_p.His445Leu | 1 | 2 | -0.827 | 0.408 | |
| rpoB_p.Ser431Cys | 1 | >16 | -1.339 | 0.180 | |
| rpoB_p.Ser428Arg | 1 | >16 | -1.339 | 0.180 | |
| 谱系 | 结核分枝杆菌 [株(构成比,%)] | 利福平耐药 基因突变株 [株(构成比,%)] |
|---|---|---|
| L1 | 2(0.44) | 0(0.00) |
| L1.2.1 | 2(0.44) | 0(0.00) |
| L2 | 398(88.44) | 128(92.09) |
| L2.1 | 2(0.44) | 0(0.00) |
| L2.2.1 | 251(55.78) | 87(62.59) |
| L2.2.1.1 | 122(27.11) | 32(23.02) |
| L2.2.1.2 | 1(0.22) | 1(0.72) |
| L2.2.2 | 21(4.67) | 8(5.76) |
| L2.2.2.1 | 1(0.22) | 0(0.00) |
| L4 | 49(10.90) | 10(7.19) |
| L4.2 | 1(0.22) | 1(0.72) |
| L4.2.1 | 1(0.22) | 1(0.72) |
| L4.2.1.1 | 1(0.22) | 1(0.72) |
| L4.2.2 | 8(1.79) | 2(1.44) |
| L4.4 | 2(0.44) | 0(0.00) |
| L4.4.1.1 | 1(0.22) | 0(0.00) |
| L4.4.2 | 18(4.00) | 3(2.16) |
| L4.5 | 16(3.56) | 2(1.44) |
| L4.8 | 1(0.22) | 0(0.00) |
| L2+L4 | 1(0.22) | 1(0.72) |
| L2.2.1,L4.6.1.2 | 1(0.22) | 1(0.72) |
| 合计 | 450(100.00) | 139(100.00) |
| [1] | 周奉, 李同心, 杨松, 等. 结核病短程治疗方案的研究进展. 中国防痨杂志, 2023, 45(3):311-317. doi:10.19982/j.issn.1000-6621.20220447. |
| [2] | Guo J, Liu R, Shi J, et al. Rarity of rpoB Mutations Outside the Rifampicin Resistance-Determining Region of Mycobacterium tuberculosis Isolates from Patients Responding Poorly to First-Line Tuberculosis Regimens in Beijing, China: A Retrospective Study. Infect Drug Resist, 2021, 14:2607-2612. doi:10.2147/IDR.S313717. |
| [3] | Liu D, Huang F, Zhang G, et al. Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China. Clin Microbiol Infect, 2022, 28(5):731.e9-731.e15. doi:10.1016/j.cmi.2021.09.014. |
| [4] | World Health Organization. Technical report on critical concentrations for drug susceptibility testing of isoniazid and the Rifamycins (Rifampicin, Rifabutin and Rifapentine). Geneva: World Health Organization, 2021. |
| [5] | 王希江, 谭云洪, 贺文从, 等. 结核分枝杆菌中利福平和异烟肼耐药相关基因突变与耐药水平的相关性研究. 中国防痨杂志, 2021, 43(3):248-254. doi:10.3969/j.issn.1000-6621.2021.03.010. |
| [6] |
Pang Y, Lu J, Wang Y, et al. Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2013, 57(2):893-900. doi:10.1128/AAC.01024-12.
pmid: 23208715 |
| [7] | 胡族琼, 刘燕文, 周文, 等. 结核分枝杆菌rpoB基因突变特征与利福平耐药水平关系的研究. 中国人兽共患病学报, 2016, 32(1):39-50. doi:10.3969/j.issn.1002-2694.2016.01.009. |
| [8] | Li MC, Lu J, Lu Y, et al. rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis. Infect Drug Resist, 2021, 14:4119-4128. doi:10.2147/IDR.S333433. |
| [9] | Solo ES, Nakajima C, Kaile T, et al. Mutations in rpoB and katG genes and the inhA operon in multidrug-resistant Mycobacterium tuberculosis isolates from Zambia. J Glob Antimicrob Resist, 2020, 22(9):302-307. doi:10.1016/j.jgar.2020.02.026. |
| [10] | Clinical and laboratory standards Institute. Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. Wayne: Clinical and laboratory standards Institute, 2023. |
| [11] | Shea J, Halse TA, Kohlerschmidt D, et al. Low-level rifampin resistance and rpoB mutations in Mycobacterium tuberculosis: an analysis of whole-genome sequencing and drug susceptibility test data in New York. J Clin Microbiol, 2021, 59: e01885-20. doi:10.1128/JCM.01885-20. |
| [12] | World Health Organization. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance,2nd ed. Geneva: World Health Organization, 2023. |
| [13] | 张洁, 任怡宣, 潘丽萍, 等. 全基因组测序在结核分枝杆菌研究中的应用. 中国防痨杂志, 2020, 42(7):737-740. doi:10.3969/j.issn.1000-6621.2020.07.017. |
| [14] | 李相辰, 柳正卫, 陆烨玮, 等. 结核分枝杆菌全基因组测序数据分析方法与应用进展. 中国防痨杂志, 2022, 44(11):1193-1198. doi:10.19982/j.issn.1000-6621.20220219. |
| [15] | 梅金周, 王云霞, 张梅娟, 等. 全基因组测序技术在耐药肺结核诊断中的应用性评价. 新发传染病电子杂志, 2024, 9(3):16-20. doi:10.19871/j.cnki.xfcrbzz.2024.03.004. |
| [16] | 蒋燕成, 张建明, 陈紫萱, 等. 结核分枝杆菌耐药基因突变特征及与耐药水平关系的研究. 检验医学与临床, 2023, 20(15):2145-2148. doi:10.3969/j.issn.1672-9455.2023.15.001. |
| [17] | 杨慧娟, 陈连勇, 茹浩浩, 等. 云南省结核分枝杆菌利福平耐药基因rpoB突变特征分析. 中华疾病控制杂志, 2018, 22(2):147-152. doi:10.16462/j.cnki.zhjbkz.2018.02.011. |
| [18] | 董春萍, 伍定辉. 厦门地区结核病患者对利福平与异烟肼的耐药情况及其耐药基因突变位点分析. 抗感染药学, 2024, 21(5):487-490. doi:10.13493/j.issn.1672-7878.2024.05-010. |
| [19] | 赵竟男, 夏辉, 江友桥, 等. 江西省利福平及异烟肼耐药结核分枝杆菌的耐药基因分子特征. 现代预防医学杂志, 2024, 51(13):2460-2465. doi:10.20043/j.cnki.MPM.202404144. |
| [20] |
Makhado NA, Matabane E, Faccin M, et al. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study. Lancet Infect Dis, 2018, 18(12):1350-1359. doi:10.1016/S1473-3099(18)30496-1.
pmid: 30342828 |
| [21] |
Levin-Reisman I, Ronin I, Gefen O, et al. Antibiotic tolerance facilitates the evolution of resistance. Science, 2017, 355(6327):826-830. doi:10.1126/science.aaj2191.
pmid: 28183996 |
| [22] |
Brauner A, Fridman O, Gefen O, et al. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol, 2016, 14(5):320-330. doi:10.1038/nrmicro.2016.34.
pmid: 27080241 |
| [23] | 李勤静, 焦伟伟. 结核分枝杆菌利福平耐药机制及其适应性研究进展. 结核病与肺部健康杂志, 2017, 6(2):106-109. doi:10.3969/j.issn.2095-3755.2017.02.005. |
| [24] | Ma P, Luo T, Ge L, et al. Compensatory effects of M.tuberculosis rpoB mutations outside the rifampicin resistance-determining region. Emerg Microbes Infect, 2021, 10(1):743-752. doi:10.1080/22221751.2021.1908096. |
| [25] | Li QJ, Jiao WW, Yin QQ, et al. Compensatory Mutations of Rifampin Resistance Are Associated with Transmission of Multidrug-Resistant Mycobacterium tuberculosis Beijing Genotype Strains in China. Antimicrob Agents Chemother, 2016, 60(5):2807-2812. doi:10.1128/AAC.02358-15. |
| [26] | 叶婧, 周崇兴, 林玫, 等. 广西边境地区与非边境地区结核分枝杆菌基因组学分析. 热带病与寄生虫学, 2023, 21(2):82-87. doi:10.3969/j.issn.1672-2302.2023.02.005. |
| [27] | Liu QY, Ma AJ, Wei LH, et al. China’s tuberculosis epidemic stems from historical expansion of four strains of Mycobacterium tuberculosis. Nat Ecol Evol, 2018, 2(12):1982-1992. doi:10.1038/s41559-018-0680-6. |
| [28] | 张书, 雷卉, 王为娜, 等. 2020—2021年凉山州4个彝族聚居县297株结核分枝杆菌耐药及菌株谱系分析. 预防医学情报杂志, 2024, 40(12):1590-1598. doi:10.19971/j.cnki.1006-4028.230601. |
| [1] | Miao Honghao, Zhang Jie, Pang Mengdi, Ren Yixuan, Deng Yang, Yi Junli, Fan Ruifang, Chen Shuangshuang, Chen Hao, Yu Lan, Li Jie, Li Chuanyou, Yang Xinyu. Genotypic and drug resistance of Mycobacterium tuberculosis in Beijing,2024 [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 477-484. |
| [2] | Jiang Lina, Dai Wenxi, Ju Hanfang, Meng Sukai, Wang Chunhua. Clinical value of auramine O fluorescence staining automatic microscopic scanning and recognition system for detecting tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 504-509. |
| [3] | Hou Tianyong, Ren Liping, Li Jingying, Wang Jianwei, Fan Shuhui, Wu Yuanming, Wang Quanhong, Ding Weimin. Clinical application value of combined molecular biology testing with bronchoalveolar lavage fluid (BALF) for diagnosing smear-negative pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 329-334. |
| [4] | Zhang Jian, Chen Bin, Zhang Mingwu, Qin Jiasheng, Song Yufang, Li Xuejing, Wang Wei. Analysis of the dynamics and influencing factors of latent tuberculosis infection in a rural elderly population in Changxing County [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 405-412. |
| [5] | Lin Weibing, Shi Yiheng, Guo Yanling, Ma Shang, Yang Bin, Long Sibo, Zheng Maike, Sun Yong, Zhao Yan, Wang Guirong. Analysis of drug resistance patterns in 241 patients with lymph node tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 247-255. |
| [6] | Tian Xiaomei, Jiang Xuefeng, Yang Xia, Sha Xiaolan, Lei Juan, Wang Xiaowei, Liu Jing. Analysis of case detection and anti-tuberculosis treatment outcomes in Mycobacterium tuberculosis/HIV co-infected patients in Ningxia from 2015 to 2023 [J]. Chinese Journal of Antituberculosis, 2026, 48(1): 57-63. |
| [7] | Jiangxi Chest Hospital/Jiangxi Provincial Key Laboratory of Tuberculosis , Guangzhou National Laboratory , Chinese Antituberculosis Association . Expert consensus on the application of host biomarkers for tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(1): 9-20. |
| [8] | Yan Yueming, Chen Meng, Li Xuekui, Wang Zhongdong, Sun Haiyan, Dai Xiaoqi, Song Song, Xu Honghong, Zhang Menghan, Wang Zhi, Lyu Kunzheng. Prevalence and influencing factors of latent tuberculosis infection among elderly residents in nursing homes in Qingdao [J]. Chinese Journal of Antituberculosis, 2025, 47(9): 1148-1153. |
| [9] | Zhu Tingting, Wang Mingzhe, Zulikatiayi Abudula, Gulina Badeerhan, Kaideliyan Abuduwaili, Wang Le. Preliminary analysis of the construction of mouse models infected with Xinjiang Uygur Autonomous Region Mycobacterium tuberculosis CAS lineage and H37Rv standard strain [J]. Chinese Journal of Antituberculosis, 2025, 47(9): 1187-1195. |
| [10] | Zhang Xiaoke, Chen Ling. Research progress on the anti-tuberculosis effect and mechanism of cinnamaldehyde on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(9): 1220-1226. |
| [11] | Chen Liyao, Peng Xiao, Liu Yuanyuan, Shi Jin, Guo Yongli, Lu Jie. The molecular mechanisms of ferroptosis and their potential applications in the diagnosis and treatment of tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(9): 1227-1232. |
| [12] | Zhang Ye, Liang Wenwen, Huo Chenchao, Shi Jinghua, Qi Xianglong, Cheng Kai, Lu Yu, Xu Jian. Synergistic effect of zuclopenthixol on the anti-tuberculosis activity of clofazimine and its mechanism of action on MmpL5-MmpS5 [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1023-1030. |
| [13] | Fan Ruifang, Dai Xiaowei, Yang Xinyu, Chen Shuangshuang, Chen Hao, Yu Lan, Zhao Yanfeng, Li Chuanyou, Wang Nenhan. A study on the identification of Mycobacterium species using fluorescent PCR probe melting curve technique and DNA microarray chip technique [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1031-1037. |
| [14] | Tuberculosis Control Branch of Chinese Antituberculosis Association, Standardization Professional Branch of Chinese Antituberculosis Association, Elderly Tuberculosis Control Branch of Chinese Antituberculosis Association. Expert consensus on the application of Mycobacterium tuberculosis infection detection technologies [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 813-829. |
| [15] | Zheng Zhuangbin, Bi Lijun, Zhang Liqun. Study on the interaction between Mycobacterium tuberculosis membrane protein MmpS5/MmpL5 and bedaquiline [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 884-892. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.